Skip to main content
. Author manuscript; available in PMC: 2014 Feb 4.
Published in final edited form as: Clin Cancer Res. 2012 Jan 18;18(5):1227–1236. doi: 10.1158/1078-0432.CCR-11-2308

Figure 2. Trend toward improved survival in MCPyV-positive MCC patients.

Figure 2

(A) Overall survival and (B) recurrence-free survival depicted according to MCPyV status, for all disease stages. Upon adjustment for the independent effects of disease stage and nodal status, statistical analysis revealed that patients with MCPyV-positive tumors showed a trend toward a longer overall survival (p=0.065) when compared to patients with no detectable virus. Values in bold indicate statistical significance. MCPyV+ (solid line) and MCPyV- (dashed line) patients (28, 29).

# adjusted for stage and nodal status